Influx of Chinese investments into US biotech sector leading to inflated funding rounds for startups
Biotech companies take over IPO market
FDA to establish expedited process for biologics applications
USDA withdraws proposal regarding gene-edited plants
MilliporeSigma and Sartorius detail bioreactor sales
First CAR-T therapy approved in US
German biotech sector growing robustly
Biotech executives protest Trump travel ban
Company announcements and product introductions
FDA issues new biosimilars guidance
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.